Wird geladen...
A Host‐Dependent Prognostic Model for Elderly Patients with Diffuse Large B‐Cell Lymphoma
BACKGROUND. Decision‐making models for elderly patients with diffuse large B‐cell lymphoma (DLBCL) treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R‐CHOP) are in great demand. PATIENTS AND METHODS. The Society of Lymphoma Treatment in Japan (SoLT‐J), in collaborat...
Gespeichert in:
| Veröffentlicht in: | Oncologist |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
AlphaMed Press
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5423505/ https://ncbi.nlm.nih.gov/pubmed/28408622 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0260 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|